The world is changing and advancing at speeds we couldn’t have ever imagined, over the last few decades life expectancy has increased dramatically around the globe, but not quality of life.
Mental healthcare has to rely on snapshot diagnostics and self-reports. Improving the status quo requires new tools that are objective, easily accessible and can track mental wellbeing over time.
EvokAI is a MedTech AI-powered company dedicated to the development of transformational and innovative technologies for the modern healthcare sector.
We deploy machine learning models to search medical data and uncover insights to help improve health outcomes, patient experiences, drug development, preclinical and clinical decisions and provide more accurate diagnoses.
EvokAI tailors its AI algorithms across the whole healthcare system, from hospitals, private clinics, research institutions, pharmaceutical companies, contract research organizations, to medical professionals, patients, healthy individuals aiming at preventing any kind of disease and beyond, protecting the aging genome.
We are paving the way for high-throughput psychometrics.
We observe performance and behaviors in virtual world setups instead of relying on self-reports.
Our approach aims at psychological concepts that were previously beyond the methodological means of psychometrics.
Our methods set new standards in test economic efficiency.
Our technology allows to monitor mental fitness based on established parameters of executive functioning and higher-level human cognition (e.g. attitudes, humor appreciation, social skills). We supplement the psychological instruments with entertaining computer games that test psychological concepts that were previously beyond the methodological means of psychometrics.
We offer the first integrative assessment of Theory-of-Mind (ToM), humor appreciation, personality and attitudes. ToM can be best described as the ability to put oneself in the position of another person and peer into someone else’s mind even when given only very little cues. ToM is a crucial skill to immediately recognize misunderstandings in social interaction allowing to approach them in a solution-oriented way. Mastering ToM is key for fruitful and beneficial social interactions in the daily routine. Deficits in ToM can play a role in a variety of psychiatric disorders such as Autism, Schizophrenia or Depression. Albeit ToM is typically better preserved than other cognitive functions, it also declines with aging.
EvokAI is a MedTech AI-powered company dedicated to the development of transformational and innovative technologies for the modern healthcare sector. We deploy machine learning models to search medical data and uncover insights to help improve health outcomes, patient experiences, drug development, preclinical and clinical decisions and provide more accurate diagnoses. EvokAI tailors its AI algorithms across the whole healthcare system, from hospitals, private clinics, research institutions, pharmaceutical companies, contract research organizations, to medical professionals, patients, healthy individuals aiming at preventing any kind of disease and beyond, protecting the aging genome.
Mental wellbeing needs to be accessible for everyone.
This requires changing the current approach:
We combine information technology, game-design and data science to break new grounds in psychology. Community participation is the last ingredient in the recipe for the psychological toolkit of the 21st century.
Alejandro Antalich Co-founder, Chairman of the Board
Mr. Antalich is the former Chief Executive Officer of the Canadian Company ICC Labs Inc. (TSXV), the first publicly traded company in the world to sell cannabis to a federal government, bridging the gap between the stigma behind certain controlled substances and regulators. Through strategic foresight, determination, commitment, responsibility, teamwork and passion, he led ICC Labs to its successful sale to Aurora (TSX) in November 2018, one of the largest participants in the industry, a $300 million transaction. An entrepreneur and investor with a commercial instinct and vision towards business growth, with expertise in public markets, mergers and acquisitions, corporate strategy, medtech and foodtech sectors, pharmaceutical industry, operations, manufacturing and product development. A savvy negotiator that manages unique relationship building skills. Focused on innovation, biotechnology, biomedical sciences and clinical research, he also leads Biomind Labs Inc., a Canadian publicly traded life sciences company specialized in fast acting psychedelics and tailored drug delivery systems targeting specific therapeutic indications. He sits on the boards of several companies.
Simon Vumbaca Board Member
Mr. Vumbaca has over 20 years of experience as a strategic advisor to senior leaders and influencers and has worked in the background globally throughout the corporate, financial and governmental worlds. He is deeply passionate about having a holistic birds-eye approach to every unique situation, considering all the angles. Simon's broad spectrum of clients includes Formula 1 racing tracks, Moto GP riders, athletes, pharmaceuticals, footballers, agents, high profile individuals and government officials. An expert in corporate strategy, public sector strategy, mergers & acquisitions, organizational strategy and functional strategy, with focus on turbo-boosting answers to the challenges companies face to ensure a successful outcome. He sits on the boards of several companies and can be available as a non-executive director. He works in English, Spanish, French, and Italian primarily.
Tuula Palmén Board Member
Mrs. Palmén has 20 years of experience in Finnish innovation and industrial policy. She has participated in planning and execution of national and regional strategies focusing on life science, biotech, pharma, food, digital health, medtech and sustainability. She led the development of Finnish synthetic biology ecosystem and its integration to global ecosystems in 2018-2022, and Health Capital Helsinki to create the basis for the Helsinki Metropolitan region to become one of the leading health hubs in Nordics and Europe in 2015-2018. She was responsible for the development of the life science field in Oulu 2006-2015 and in Helsinki 2003-2006. She received her Ph.D from the University of Helsinki in 2003. She also is eMBA from Hanken School of Economics & SSE in 2020. Further, Mrs. Palmén has over 10 years of experience in international business in sales and marketing, in medical device, diagnostic and biotech industry at KONE Corporation, Tamro Corporation and Immuno Diagnostics.
EvokAI and the University of Basel bring to your door the solution for your mental wellbeing. Founded in 1460, the University of Basel is the oldest university in Switzerland and has a history of success going back over 550 years. Worthy of a Nobel Prize, two researchers working at the University of Basel have received the Nobel Prize for Physiology or Medicine.